🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The ARTEMIS-IPF study was conducted to determine if ambrisentan was effecti...
Status
Terminated
Location
University of Alabama at Birmingham Hospital
Start Date
2008-12
Trial ID
NCT00768300
Treatments Being Tested
A surveillance of respiratory tract related adverse events in patients trea...
Status
Completed
Location
Cardiovascular Associates, P.C.
Start Date
2010-12
Trial ID
NCT01266265
Under placebo control, the investigators intend to evaluate the effectivene...
Status
Unknown
Location
Renji Hospital
Start Date
2020-08-01
Trial ID
NCT04528056
Treatments Being Tested
The primary goal of the study is to determine the safety and tolerability o...
Status
Completed
Location
Augusta University
Start Date
2015-09
Trial ID
NCT02712346
Treatments Being Tested
Patients with COVID-19 frequently develop lower respiratory complications. ...
Status
Terminated
Location
General Hopital Zadar
Start Date
2021-02-08
Trial ID
NCT04771000
Treatments Being Tested
The purpose of this study is to investigate the effectiveness of a drug cal...
Status
Completed
Location
Nilanjana Bose, Md
Start Date
2010-02
Trial ID
NCT01072669
Treatments Being Tested
AMB-320/321-E was designed to provide long-term, controlled monitoring of p...
Status
Completed
Location
Sanatorio Otamendi
Start Date
2004-02
Trial ID
NCT00578786
Treatments Being Tested
The objective of this post-marketing surveillance study is to evaluate the ...
Status
Completed
Location
Multiple Locations
Start Date
2010-12-14
Trial ID
NCT01406327
Treatments Being Tested
Trial Design Patients with borderline PAH indicated by borderline mPAP valu...
Status
Completed
Location
Thoraxclinic at the University of Heidelberg
Start Date
2014-07-01
Trial ID
NCT02290613
Treatments Being Tested
It is hypothesised that ambrisentan may provide benefit to subjects with in...
Status
Terminated
Location
GSK Investigational Site
Start Date
2013-09
Trial ID
NCT01884675
Treatments Being Tested